The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study

Trial Profile

The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study

Completed
Phase of Trial: Phase III

Latest Information Update: 02 May 2017

At a glance

  • Drugs Tolvaptan (Primary) ; Furosemide
  • Indications Acute heart failure
  • Focus Therapeutic Use
  • Acronyms TACTICS-HF
  • Most Recent Events

    • 13 Sep 2016 Primary endpoint (Dyspnea improvement measured by Likert scale at 8 and 24 hours) has not been met according to the results published in the Journal of the American College of Cardiology.
    • 13 Sep 2016 Results published in the Journal of the American College of Cardiology.
    • 10 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top